Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery
Surgery Today · 2024-10 · 54 (10) · 1146-1153
DOI: 10.1007/s00595-024-02811-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 14.03.2024. Verfasst von Masaru Takenaka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. m-takenaka@med.uoeh-u.ac.jp. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Salvage Therapy, Lung Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. m-takenaka@med.uoeh-u.ac.jp.
- Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
- Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Zitieren
APA
Takenaka, M., Tanaka, F., Kajiyama, K., Manabe, T., Yoshimatsu, K., Mori, M., Kanayama, M., Taira, A., Kuwata, T., Nawata, A., & Kuroda, K. (2024). Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery. Surgery Today, 54(10), 1146-1153. https://doi.org/10.1007/s00595-024-02811-3
Vancouver
Takenaka M, Tanaka F, Kajiyama K, Manabe T, Yoshimatsu K, Mori M, et al. Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery. Surgery Today. 2024;54(10):1146-1153. doi:10.1007/s00595-024-02811-3
BibTeX
@article{Takenaka2024,
author = {Takenaka, Masaru and Tanaka, Fumihiro and Kajiyama, Kenta and Manabe, Takehiko and Yoshimatsu, Katsuma and Mori, Masataka and Kanayama, Masatoshi and Taira, Akihiro and Kuwata, Taiji and Nawata, Aya and Kuroda, Koji},
title = {Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery},
journal = {Surgery Today},
year = {2024},
volume = {54},
number = {10},
pages = {1146--1153},
doi = {10.1007/s00595-024-02811-3}
}
EUVIMED